Works matching IS 00099104 AND DT 2017 AND VI 188 AND IP 3

Results: 17

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 412, doi. 10.1111/cei.12951
By:
- Schaper, F.;
- de Leeuw, K.;
- Horst, G.;
- Maas, F.;
- Bootsma, H.;
- Heeringa, P.;
- Limburg, P. C.;
- Westra, J.
Publication type:
Article
Chronic norovirus infection and common variable immunodeficiency.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 363, doi. 10.1111/cei.12884
By:
- Woodward, J.;
- Gkrania‐Klotsas, E.;
- Kumararatne, D.
Publication type:
Article
UK NEQAS survey of allergen component testing across the United Kingdom and other European countries.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 387, doi. 10.1111/cei.12950
By:
- Saleem, R.;
- Keymer, C.;
- Patel, D.;
- Egner, W.;
- Rowbottom, A. W.
Publication type:
Article
Considerations for dosing immunoglobulin in obese patients.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 353, doi. 10.1111/cei.12955
By:
- Hodkinson, J. P.
Publication type:
Article
Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 420, doi. 10.1111/cei.12921
By:
- Jiao, Q.;
- Liu, C.;
- Li, W.;
- Fang, F.;
- Qian, Q.;
- Zhang, X.
Publication type:
Article
Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 394, doi. 10.1111/cei.12940
By:
- Jeffery, H. C.;
- Jeffery, L. E.;
- Lutz, P.;
- Corrigan, M.;
- Webb, G. J.;
- Hirschfield, G. M.;
- Adams, D. H.;
- Oo, Y. H.
Publication type:
Article
Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 430, doi. 10.1111/cei.12941
By:
- Steiner, U. C.;
- Keller, M.;
- Schmid, P.;
- Cichon, S.;
- Wuillemin, W. A.
Publication type:
Article
Sarcoidosis extent relates to molecular variability.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 444, doi. 10.1111/cei.12942
By:
- Monast, C. S.;
- Li, K.;
- Judson, M. A.;
- Baughman, R. P.;
- Wadman, E.;
- Watt, R.;
- Silkoff, P. E.;
- Barnathan, E. S.;
- Brodmerkel, C.
Publication type:
Article
Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 455, doi. 10.1111/cei.12949
By:
- Bommarito, D.;
- Hall, C.;
- Taams, L. S.;
- Corrigall, V. M.
Publication type:
Article
Clinical challenges in the management of patients with B cell immunodeficiencies.
Published in:
2017
By:
- Hodkinson, J. P.;
- Chapel, H.
Publication type:
Editorial
Differential responses of human dendritic cells to metabolites from the oral/airway microbiome.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 371, doi. 10.1111/cei.12943
By:
- Whiteson, K.;
- Agrawal, S.;
- Agrawal, A.
Publication type:
Article
Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 380, doi. 10.1111/cei.12944
By:
- Egner, W.;
- Helbert, M.;
- Sargur, R.;
- Swallow, K.;
- Harper, N.;
- Garcez, T.;
- Savic, S.;
- Savic, L.;
- Eren, E.
Publication type:
Article
The role of genomics in common variable immunodeficiency disorders.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 326, doi. 10.1111/cei.12947
By:
- Kienzler, A.‐K.;
- Hargreaves, C. E.;
- Patel, S. Y.
Publication type:
Article
Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 342, doi. 10.1111/cei.12948
By:
- Misbah, S. A.
Publication type:
Article
When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 333, doi. 10.1111/cei.12915
By:
- Jolles, S.;
- Chapel, H.;
- Litzman, J.
Publication type:
Article
Association of peripheral NK cell counts with Helios+IFN-γ- Tregs in patients with good long-term renal allograft function.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 467, doi. 10.1111/cei.12945
By:
- Trojan, K.;
- Zhu, L.;
- Aly, M.;
- Weimer, R.;
- Bulut, N.;
- Morath, C.;
- Opelz, G.;
- Daniel, V.
Publication type:
Article
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.
Published in:
Clinical & Experimental Immunology, 2017, v. 188, n. 3, p. 437, doi. 10.1111/cei.12946
By:
- Negm, O. H.;
- MacKenzie, B.;
- Hamed, M. R.;
- Ahmad, O. A. J.;
- Shone, C. C.;
- Humphreys, D. P.;
- Ravi Acharya, K.;
- Loscher, C. E.;
- Marszalowska, I.;
- Lynch, M.;
- Wilcox, M. H.;
- Monaghan, T. M.
Publication type:
Article

Works matching IS 00099104 AND DT 2017 AND VI 188 AND IP 3

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Chronic norovirus infection and common variable immunodeficiency.

UK NEQAS survey of allergen component testing across the United Kingdom and other European countries.

Considerations for dosing immunoglobulin in obese patients.

Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.

Low-dose interleukin-2 promotes STAT-5 phosphorylation, T<sub>reg</sub> survival and CTLA-4-dependent function in autoimmune liver diseases.

Mutational spectrum of the SERPING1 gene in Swiss patients with hereditary angioedema.

Sarcoidosis extent relates to molecular variability.

Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1.

Clinical challenges in the management of patients with B cell immunodeficiencies.

Differential responses of human dendritic cells to metabolites from the oral/airway microbiome.

Chlorhexidine allergy in four specialist allergy centres in the United Kingdom, 2009-13: clinical features and diagnostic tests.

The role of genomics in common variable immunodeficiency disorders.

Progressive multi-focal leucoencephalopathy - driven from rarity to clinical mainstream by iatrogenic immunodeficiency.

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

Association of peripheral NK cell counts with Helios<sup>+</sup>IFN-γ<sup>-</sup> T<sub>regs</sub> in patients with good long-term renal allograft function.

Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration.